Clinical Trial

Dimotec (Diosmin) 1000 mg Film Coated Tablet Fed Study

Study acronym: Diosmin
Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated July 16, 2026 (before its estimated August 16, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to compare the bioavailability of Dimotec 1000 mg film-coated tablet (Test; Keri Pharma Hungary Kft.) with Detralex 1000 mg film-coated tablets (Reference; Les Laboratoires Servier Industrie, France) in healthy adult human participants under fed conditions. The study will also evaluate the safety and tolerability of a single dose of the investigational products.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-07-17
minor Completion pushed: 2026-08-27 -> 2026-12-29 2026-07-17
Trial Details
NCT Number NCT07674446
Lead Sponsor Keri Pharma Hungary Kft
Conditions Healthy Volunteers
Enrollment 72 participants
Start Date 2026-06-29
Primary Completion 2026-08-16 (estimated)
Study Completion 2026-12-29 (estimated)
Updated on ClinicalTrials.gov 2026-07-16